Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival
- Xie, Tao, Dickson, Kristie-Ann, Yee, Christine, Ma, Yue, Ford, Caroline E., Bowden, Nikola A., Marsh, Deborah J.
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients
- Jacob, Francis, Ukegjini, Kristjan, Fink, Daniel A., Hacker, Neville F., Heinzelmann-Schwarz, Viola A., Nixdorf, Sheri, Ford, Caroline E., Olivier, Jake, Caduff, Rosmarie, Scurry, James P., Guertler, Rea, Hornung, Daniela, Mueller, Renato
Are you sure you would like to clear your session, including search history and login status?